A randomised trial to evaluate the effects of didgeridoo playing on snoring

ISRCTN ISRCTN31571714
DOI https://doi.org/10.1186/ISRCTN31571714
Secondary identifying numbers N/A
Submission date
25/02/2005
Registration date
26/04/2005
Last edited
27/07/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Milo Puhan
Scientific

Horten Centre
University Hospital
Postfach Nord
Zurich
8091
Switzerland

Phone +41 1 255 87 09
Email milo.puhan@evimed.ch

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSnoring and apnoea-hypopnea-index 15-30
InterventionIntervention group: Playing Didgeridoo for a period of four months, at least five times a week. Regular instructions by professional Didgeridoo-Teacher.
Control group: No Didgeridoo playing for a period of four months.
Intervention typeOther
Primary outcome measure1. Epworth scale
2. Pittsburgh Sleep Quality Index
3. 36-item Short Form health survey (SF-36)
4. Proxy evaluation
5. Apnoea-hypopnea-index
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/08/2004
Completion date01/04/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
Lower age limit18 Years
SexNot Specified
Target number of participants30
Key inclusion criteria30 patients of at least 18 years of age with snoring and apnoea-hypopnea-index 15-30.
Key exclusion criteria1. Treatment for sleep apnoea (e.g. with continuous positive airway pressure [CPAP])
2. Body Mass Index greater than 30
3. More than seven drinks per week
4. Regular intake of psychostimulating drugs and current or planned weight reduction intervention
Date of first enrolment01/08/2004
Date of final enrolment01/04/2005

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Horten Centre
Zurich
8091
Switzerland

Sponsor information

Zürcher Höhenklinik Wald (Switzerland)
Hospital/treatment centre

-
Faltigberg-Wald
8639
Switzerland

Email info@zhw.ch
Website http://www.zhw.ch/

Funders

Funder type

Hospital/treatment centre

Zürcher Höhenklinik Wald (Switzerland)

No information available

Zürcher Lungenliga (Switzerland)

No information available

Praxis Alex Suarez (Switzerland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 04/02/2006 Yes No